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Abstract—Primary care research databases provide a signif-
icant resource for health services and epidemiological research.
However since data are recorded primarily for clinical care
their suitability for research may vary widely according to the
research application or recording practices of individual general
practitioners. A methodological approach for characterising
data quality is required. We describe a one-day workshop
entitled “Towards a common protocol for measuring and
monitoring data quality in European primary care research
databases”. Researchers, database experts and clinicians were
invited to give their perspectives on data quality and to
exchange ideas on what data quality metrics should be made
available to researchers. We report the main outcomes of
this workshop, including a summary of the presentations and
discussions and suggested way forward.
I. INTRODUCTION
The potential for using routinely collected patient records
for research purposes has been steadily increasing with the
recent advances and diminishing technical barriers in data
storage and information processing. Primary care records
are created on, or close to, the date that an event occurs
and record all interactions with the general practitioner (GP)
including tests, prescriptions and referrals to secondary care.
However, records are variable in quality and may be missing
or incompletely recorded. Since the validity of results relies
on the quality of the data, it is important to have processes in
place for assessing this variability and ensuring that data is
of high quality with respect to their intended use. Although
there is a vast literature on data quality in general, and many
different frameworks have been proposed, there is still a
need to categorise different dimensions of quality and to
standardise the benchmarks for each dimension.
Data quality is a multidimensional concept which depends
on the use that is being made of the data, i.e. “fitness for
use” [1]. Different dimensions will be more important for
some groups of user than others. This workshop brought
together clinicians, users of the data and database experts
to discuss what data quality means to them and to develop
a common approach for measuring data quality in primary
care European databases. The specific aims were to:
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1) Share experiences of assessing data quality in electronic
health records (EHRs).
2) Discuss the issues and challenges involved with mea-
suring data quality in EHRs for epidemiological and
clinical research.
3) Work towards development of an approach to ensure
compatibility of data quality measures for different
European primary and secondary care databases.
4) Discuss how to help data contributors improve data
quality (for both clinical care and research) at source.
The workshop was held at the Clinical Practice Research
Datalink in London and was organised by the authors who
chaired and facilitated the four sessions. These were arranged
as two sets of short 10-minute presentations: A. Data quality
in European research databases and B. Data quality from
the users point of view and two discussion sessions: C.
The clinical perspective (panel session) and D. Break-out
discussions. The 42 invited attendees included statisticians,
epidemiologists, general practitioners, clinician researchers,
IT professionals and representatives from the Primary Care
Information Services (PRIMIS). In advance of the workshop,
all invitees were asked to provide answers to a questionnaire
aimed at understanding what drives interest in data quality
and how it is approached. We summarise the presentations,
discussion and questionnaire answers and provide sugges-
tions for a proposed way forward.
II. SUMMARY OF PRESENTATIONS
A. Data quality in European research databases
1) Data quality in the Clinical Practice Research Datalink
(CPRD): Rosemary Tate described an investigation of data
quality in the CPRD Gold database [2]. Percentages of data
elements relating to different dimensions of data quality were
extracted for all 538 practices contributing to the database be-
tween 2000-2011 and investigated using summary statistics,
graphs and correlation analysis. Recording of most elements
improved over time. There were large inter-practice vari-
ations, and most percentages had left-skewed distributions
with several outliers. Most percentages were only weakly
inter-correlated, except those related to specific conditions
(e.g. tests and measures for diabetes). GP practices who
were weak at recording one aspect were generally fine at
recording all others. She concluded that practice-based DQ
scores should be tailored to the intended use of the data.
2) Data quality in a primary care Catalan Database:
Leonardo Me´ndez (SIDIAP) described the Registry Quality
Score (RQS) scoring system that has been developed in order
to select research-useable data from the SIDIAP database
containing records from 274 primary care practices, repre-
senting 80% of the Catalan population [3]. The method is
based on comparing disease prevalence rates in GP practices
with the expected prevalence obtained either from literature
or from ”gold standards” such as disease or mortality reg-
isters. The prevalence rates were compared against those
expected and used to assign scores to practices and staff.
Only data above a certain score threshold was selected as
research useable. These data were shown to be representative
of the whole database and the Catalan population with
respect to age, sex and geographical distribution; and have
been validated for several diseases and mortality against
gold standard registers. Recently introduced feedback to
clinicians identifying patients with disagreement between
new diagnosis, diagnosing criteria and prescriptions (poor
data quality) produced a 66% improvement over 8 months.
Feedback to clinicians is key to improve data quality.
3) Data quality in a Norwegian primary care database:
Gustav Bellika (University of Tromso) described the state of
the art in the use of primary care data for research in Norway
and outlined the barriers that still need to be overcome.
Although quality of recording in primary care is good for
demographic, prescriptions and lab data, GPs use text, rather
than codes. Gustav concluded that data quality can only be
improved if providers use the data and that secondary users
of the data have trust. They are deploying a surveillance
system for infections diseases (SNOW) [4], which they hope
will incentivise GPs to provide better quality data. Feedback
loops to health professionals is believed to be essential for
both improvement of coding practices, and clinical quality.
4) Data Quality Vector: Metrics for Biomedical Data
Quality Assessment. Juan M Garcia-Gomez (IMBIE): Data
quality studies have been based mainly on dimensions,
procedures or requirements. However, there is a lack of con-
sistency and generalization in current methods for biomedical
data quality assessment, e.g. most studies focus on the
semantic analysis and the use of health information standards
and, in general, it is assumed that the probability distributions
of data are static. The effects on data quality caused by
data distributional shifts have been generally ignored. Juan
presented a general framework, the Data Quality Vector
(Saez et al, 2012), for the assessment of biomedical data
quality, based in a set of probabilistic and semantic metrics
associated with nine data quality dimensions (i.e predictive
value, correctness, duplicity, consistency, completeness, con-
textualisation, temporal-stability, spatial-stability and relia-
bility). This method is parametrizable and comparable across
different domains, with special emphasis being put on the
spatial and temporal stability of the data (Saez et al. 2013).
B. Data users and application of the data.
1) Data quality in epidemiological research: Liam
Smeeth (LSHTM) discussed issues in data quality covering
the different variables used in research, including outcomes,
exposures and covariates. He provided examples showing
how the implications of poor data quality and missing data
can impact results. The impact will often be hidden, par-
ticularly if errors are differential across comparison groups,
when bias can occur in any direction. Non-differential error
will tend to bias towards the null leave residual (hidden) con-
founding. Specificity of outcome is of particular importance:
false positive classification of outcomes will attenuate effect
sizes and can obscure real beneficial or harmful effects.
2) Data quality and the primary care research network
(PCRN): Greg Mickiewicz (PCRN). The PCRN provides
infrastructure (e.g. research staff, funding to cover practice-
based staff time, training) for conducting research in primary
care settings and supports a wide range of research projects
including: disease prevention, health promotion, screening
and early diagnosis, as well as the management of long-
term conditions. PCRN acts as the conduit for study teams
to access patient-specific data, but does not hold such data.
Greg described some of the implications of poor quality for
the data which they do hold, which could include selecting
the wrong sites for a clinical trial, failure to recruit to time
and target, or over recruiting and making incorrect payments
all with consequences for the study budget.
3) Data quality from the Pharmacoepidemiology point of
view: Cathy Emmas (Astra Zeneca). Pharmaceutical com-
panies routinely use primary care research database in their
research. Cathy described some issues affecting data quality
such as use of generic, non-specific or idiosyncratic Read
codes or incomplete dosage information. She described the
potential impact of poor data quality, such as extra time
needed to assess DQ issues and to clean/reconstruct the
data, the reduced sample size (and statistical power) due to
incomplete data, and the validity of results, which could lead
to missing disease and drug associations.
III. PANEL DISCUSSION: CLINICIANS PERSPECTIVE
Three clinicians (Dipak Kalra (UCL)), Tim Holt (Univer-
sity of Oxford) and Gro Berntsen (University of Tromso))
were asked for their position on three questions. Their
answers and the ensuing discussions are summarised below
1) Given the many uses and users of primary care infor-
mation, can there ever be a standard definition and metrics
for data quality?: Quality is defined by ISO9000 as: “the
degree to which a set of inherent characteristics fulfills
requirement”. In our experience different requirements for
use of data may rely upon different characteristics of quality
and in turn, different kinds of error may impact differently on
different requirements. Since primary care information can
be used for multiple purposes, there will never be a standard
definition of its quality. The teams that generate personal
health data are focused on clinical care rather than research,
often with limited awareness of the data quality needs of
quality assurance, governance, epidemiology, comparative
effectiveness research etc. Although quality metrics can
be defined, those of greatest importance to research, e.g.
the accuracy of blood pressure recording and avoidance of
rounding the observed values, might be difficult to impose
on clinicians unless they have an impact on the standard of
patient care.
2) Do you see any ‘conflicts of interest’ between the
different uses made of EHR information, that may impact
on the accuracy and completeness of what is documented
by clinicians?: There is an internationally recognised bias
in clinical documentation in areas that directly impact on
reimbursement, often called gaming [5]. English GPs might
be influenced by payments associated with particular Quality
Outcomes Framework (QOF) incentivised clinical codes,
with un-measured areas of clinical work receiving less at-
tention. Another potential influence is the role of the GP as
patient advocate, where they might emphasise certain clinical
findings to justify an investigation or referral.
3) What would be the persuasive influences (perhaps,
incentives) that you would favour most to help improve the
quality of clinical documentation?: Some aspects of data
quality can be enforced by well designed clinical systems,e.g.
by ensuring that numeric values are within physiological
ranges, that clinical terms are appropriate to their context.
However, system checks cannot normally detect incorrect but
plausible values or be used to prevent fields being left blank
(without annoying users). Providing practices feedback on
their data quality, as pioneered by PRIMIS in the UK and
NOKLUS in Norway, has made an important contribution
to practices that are motivated to have good quality data:
providing feed-back loops, which informs them in a non-
punitive way about the quality of their work. This has
positive effects on both data-quality and clinical quality [6].
However clinicians are unlikely to prioritise data quality
unless it benefits patient care (at individual or practice
population level) or it affects their payments. GPs take a
pragmatic approach and coding behaviour (e.g. code speci-
ficity) is influenced by what is likely actually to influence
management. A critical success factor for the future will
be to ensure that good quality data delivers value to those
individuals who capture them, for example through decision
support, alerts, charts of trends etc. It may also be influential
if clinical effort investments in data quality can be perceived
as beneficial by patients themselves. Further work is probably
needed to understand the costs and benefits of improving data
quality.
IV. REPORTS FROM BREAKOUT GROUPS
Attendees were asked to classify themselves as either a
clinician, data expert, data user or database manager and
to form round table groups according to their classification.
They were asked these two questions and given approxi-
mately 45 minutes to discuss.
1) What is the most important characteristic of data that
determines its quality, from your perspective (for the type
of data that you most often contribute or use)? : Three
of the four groups (clinicians, data experts and data users)
highlighted the importance of the breadth, or completeness,
of the available data in order to interpret a specific piece
of information in a broader context. The clinicians gave the
examples of laboratory test results and prescribing records.
The data users discussed the value of uncoded, unstructured
text data, recorded by clinicians to support coded entries,
and the potential to link patient records to other sources
of data (e.g. CPRD GOLD primary care data linked to
external secondary care, disease registry and mortality data).
They also stressed the importance of being able to assess
completeness on a study specific basis from an early stage
in feasibility analysis and discussions. Reliability, in terms
of data being consistent across an individuals patient record,
was also raised by three groups (data experts, data users and
database managers). Data users stressed the importance of
being able to establish reliable start and end dates for patient
follow-up in order to be able to follow patients over time.
Data managers discussed the complexity introduced when
the same data item can be recorded in a number of different
ways, and the need to evaluate any consistent differences in
the value of the original data item that may be dependent
on the way it was entered. Validity was highlighted by three
different groups from slightly different perspectives. The data
experts discussed the value of being able to discuss the
data with knowledgable clinicians who could establish the
original meaning in order to avoid misinterpretation. The
data users discussed the worth of being able to contact the
data providers and conduct validation questionnaires around
key events and records of interest. They also focused on
the importance of external validity, in order to be able to
generalise study results to broader population groups than
those captured in the data itself. Other data characteristics
mentioned by only one group included accuracy (clinicians),
reasons for poor data quality (data users), timeliness, in-
tegrity over time, and transparency of methods used to
calculate derived variables (database managers).
2) In your opinion, what would be the best approach to
measure and report / represent data quality.: Data users and
data managers agreed on the value of calculating and pro-
viding multi-dimensional aspects of data quality on a study
specific basis, to build upon the current standard methods
applied to individual patients and GP practices regardless of
individual study requirements. It was also suggested that, due
to variation in recording practices across clinicians within
a GP practice, calculation of a data quality metric at the
clinician level may further aid data users. Database man-
agers suggested flagging incomplete records and implausible
values, ideally as part of the data processing. Some of the
broader concepts discussed in response to the first question
were highlighted as key methods for measuring data quality,
including research collaborations between data users and
clinicians to aid interpretation of data items, triangulation of
data sources through linkages methods. Validation studies,
including incidence and prevalence calculated from the data
source and compared to external sources, were also high-
lighted. Communication of data quality metrics and results
more broadly was discussed by three groups (clinicians, data
experts and data users). Data experts stressed the importance
of providing recording guidelines to clinicians and feeding
back data quality metrics directly to them, to support them
in identifying areas for improvement. Others highlighted the
importance of the publication of data quality work to inform
the understanding of third parties, including future users of
the data, regardless of whether this was the primary focus
of a particular research study, or an early phase of data
exploration. This should include how different parties handle
the various aspects of data quality, and the algorithms used
for the identification of outcomes, including codelists.
V. SUMMARY OF RESPONSES TO THE QUESTIONNAIRE
Completed questionnaires were received from 24 invitees
which included some who were unable to attend. Participants
were asked to specify their interest in data quality (classifi-
cations as in previous section) with the majority classifying
themselves as data users. Responses to questions around key
characteristics and the measuring and recording of data qual-
ity largely reflected the discussion in the breakout session
as summarised above. The respondents generally recognised
data quality as something fundamental to delivering to a high
standard within their respective fields, be this to ensure reli-
able data for secondary use, to ensure high quality research
or for the development of data standards for EHR. In terms of
what participants hoped to gain from attending the workshop,
there was a broad consensus of a need to gain insight into
data quality issues in the wider data community. Interest
was expressed in the different approaches and concerns both
within groups of similar function and for groups providing
a function on which ones work may rely, for example, for
researchers understanding the data quality processes at the
data collection stage.
VI. CONCLUSIONS
When this workshop was first proposed we had expected
that different groups would have quite different perspectives
on data quality. However, there was a surprising amount of
consensus. It was generally agreed that incentivising GP’s to
produce higher quality data is key, either by feedback loops,
or by demonstrating how the data could be used to benefit
their own patients. Although most researchers were mainly
interested in aspects of data quality that were relevant to their
own work, there was general consensus on the characteristics,
that were important (particularly completeness, reliability
and validity) and most agreed that data should be made
available “warts and all” so users can make decision on
whether or not and how to use the data. All agreed that it is
important to have transparency on how the data is collected,
and to understand the processes involved. Although there
was awareness that primary care data has many limitations
it was also generally agreed that they are extremely useful
for research, provided that DQ issues are understood.
Although the workshop did not result in a proposed overall
approach for measuring data quality, many of the participants
(and questionnaire respondents) indicated that they would
be interested in joining a European data quality network to
discuss these issues further in order to develop a unified
approach.
VII. WAY FORWARD
Based on the results of this workshop our suggestions for
the way forward are summarised below.
1) Data providers
• Provide meta-data and practice-based data quality
scores to users, bearing in mind that DQ depends
on the use of the data.
• Be transparent about how data is handled and
provide as much information on what has been done
to the data - from start to finish.
• Provide information/training on how data is
recorded at source.
• Explore ways to incentivise GPs to record better
e.g. feedback data quality information. Explore
ways to incentivise GPs by finding ways of letting
them access the database to treat their patients.
2) Data users/experts
• Communicate impact of data quality on primary
care data research to clinicians.
• Be aware of the limitations and impact of poor
quality when carrying out research.
• Document or publish operational definitions so that
researchers can easily validate research.
3) Clinicians
• Encourage training of staff within general practice
to record data using coding as much as possible.
4) All
• Set up a European network which will continue the
discussions of the workshop in order to develop a
unified approach for measuring and improving data
quality in European Primary Care (and linked data)
research databases.
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